NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 165 filers reported holding NEVRO CORP in Q2 2019. The put-call ratio across all filers is 5.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,646,000 | -16.1% | 9,508 | -32.8% | 0.01% | -23.1% |
| Q3 2020 | $1,962,000 | +16.2% | 14,141 | 0.0% | 0.01% | +8.3% |
| Q2 2020 | $1,689,000 | +19.4% | 14,141 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,414,000 | -14.6% | 14,141 | 0.0% | 0.01% | +9.1% |
| Q4 2019 | $1,655,000 | +31.1% | 14,141 | -3.7% | 0.01% | +22.2% |
| Q3 2019 | $1,262,000 | -27.1% | 14,680 | -45.0% | 0.01% | -18.2% |
| Q2 2019 | $1,730,000 | +3.7% | 26,680 | 0.0% | 0.01% | -8.3% |
| Q1 2019 | $1,668,000 | +60.7% | 26,680 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $1,038,000 | -31.8% | 26,680 | 0.0% | 0.01% | -27.3% |
| Q3 2018 | $1,521,000 | -28.6% | 26,680 | 0.0% | 0.01% | -31.2% |
| Q2 2018 | $2,130,000 | +180.3% | 26,680 | +204.4% | 0.02% | +166.7% |
| Q1 2018 | $760,000 | +21.0% | 8,764 | -3.7% | 0.01% | +20.0% |
| Q4 2017 | $628,000 | – | 9,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
| Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
| Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
| Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
| BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
| ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
| ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
| Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
| Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
| Olympiad Research LP | 25,046 | $210,887 | 0.16% |